Treatment of fulminant liver failure by transplantation of microencapsulated primary or immortalized xenogeneic hepatocytes

Xenotransplantation

Volumn 12, Issue 6, 2005, Pages 457-464

  Mai, Gang ^a,b   Huy, Nguyen Tuan ^c   Morel, Philippe ^a   Mei, Jie ^a,d   Andres, Axel ^a   Bosco, Domenico ^a   Baertschiger, Reto ^a   Toso, Christian ^a   Berney, Thierry ^a   Majno, Pietro ^a   Mentha, Gilles ^a   Trono, Didier ^c,e   Buhler, Leo H ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b SICHUAN UNIVERSITY   (China)

^c UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^d SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^e EPFL   (Switzerland)

Author keywords

Cryopreservation; Encapsulation; Fulminant liver failure; Hepatocytes; Xenotransplantation

Indexed keywords

ALBUMIN; ALGINIC ACID; COLLAGENASE; LENTIVIRUS VECTOR; PARACETAMOL; TELOMERASE; VIRUS LARGE T ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL IMMORTALIZATION; CELL VIABILITY; CONTROLLED STUDY; CRYOPRESERVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATOCYTE TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER FAILURE; LIVER METABOLISM; MALE; MICROENCAPSULATION; MOUSE; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; RAT; SURVIVAL RATE; XENOGRAFT;

ALBUMINS; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; HEPATOCYTES; HUMANS; LIVER FAILURE, ACUTE; MALE; MICE; RATS; SURVIVAL RATE; TRANSPLANTATION, HETEROLOGOUS;

EID: 27144532822     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2005.00248.x     Document Type: Article

References (35)

1. BROERING DC, STERNECK M, ROGIERS X. Living donor liver transplantation. J Hepatol 2003; 38: S119.
2. PAPPAS SC, ROUCH DA, STEVENS LH. New techniques for liver transplantation: reduced-size, split-liver, living-related and auxiliary liver transplantation. Scand J Gastroenterol Suppl 1995; 208: 97.
3. LIU JP, GLUUD LL, ALS-NIELSEN B, GLUUD C. Artificial and bioartificial support systems for liver failure. Cochrane Database Syst Rev 2004; 1: CD003628.
4. JONES SK. When the liver fails: new help-and hope. RN 2003; 66: 32.
5. STROM SC, FISHER RA, THOMPSON MT et al. Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation 1997; 63: 559.
6. TACKABERRY ES, GANZ PR. Xenotransplantation: assessing the unknowns. Can Med Assoc J 1998; 159: 41.
7. NAGATA H, ITO M, CAI J et al. Treatment of cirrhosis and liver failure in rats by hepatocyte Xenotransplantation. Gastroenterology 2003; 124: 422.
8. SEGLEN PO. Preparation of rat liver cells. III-Enzymatic requirements for tissue dispersion. Exp Cell Res 1973; 82: 391.
9. SEGLEN PO. Preparation of isolated rat liver cells. Methods Cell Biol 1976; 13: 29.
10. NGUYEN TH, OBERHOLZER J, BIRRAUX J et al. Highly efficient lentiviral vector-mediated transduction of nondividing, fully reimplantable primary hepatocytes. Mol Ther 2002; 6: 199.
11. CUDRE-MAUROUX C, OCCHIODORO T, KONIG S et al. Lentivector-mediated transfer of Bmi-1 and telomerase in muscle satellite cells yields a Duchenne myoblast cell line with long-term genotypic and phenotypic stability. Hum Gene Ther 2003; 14: 1525.
12. SALMON P, OBERHOLZER J, OCCHIODORO T et al. Reversible immortalization of human primary cells by lentivector-mediated transfer of specific genes. Mol Ther 2000; 2: 404.
13. CANAPLE L, NURDIN N, ANGELOVA N et al. Maintenance of primary murine hepatocyte functions in multicomponent polymer capsules - in vitro cryopreservation studies. J Hepatol 2001; 34: 11.
14. BIRRAUX J, GENIN B, MATTHEY-DORET D et al. Hepatocyte cryopreservation in a three-dimensional structure. Transplant Proc 2002; 34: 764.
15. GREENE AK, PUDER M. Partial hepatectomy in the mouse: technique and perioperative management. J Invest Surg 2003; 16: 99.
16. HE Y, ZHOU J, DOU KF, CHEN Y. A rat model for acute hepatic failure. Hepatobiliary Pancreat Dis Int 2003; 2: 423.
17. FERRET PJ, HAMMOUD R, TULLIEZ M et al. Detoxification of reactive oxygen species by a nonpeptidyl mimic of superoxide dismutase cures acetaminophen-induced acute liver failure in the mouse. Hepatology 2001; 33: 1173.
18. WALKER RM, RACZ WJ, MCELLIGOTT TF. Acetaminophen-induced hepatotoxic congestion in mice. Hepatology 1985; 5: 233.
19. WALKER RM, RACZ WJ, MCELLIGOTT TF. Acetaminophen-induced hepatotoxicity in mice. Lab Invest 1980; 42: 181.
20. DABOS KJ, NELSON LJ, BRADNOCK TJ et al. The simulated microgravity environment maintains key metabolic functions and promotes aggregation of primary porcine hepatocytes. Biochim Biophys Acta 2001; 1526: 119.
21. YAMASHITA Y, SHIMADA M, TSUJITA E et al. The efficacy of nafamostat mesilate on the performance of a hybrid-artificial liver using a polyurethane foam/porcine hepatocyte spheroid culture system in human plasma. Int J Artif Organs 2001; 24: 34.
22. YAMASHITA Y, SHIMADA M, TSUJITA E et al. Polyurethane foam/spheroid culture system using human hepatoblastoma cell line (Hep G2) as a possible new hybrid artificial liver. Cell Transplant 2001; 10: 717.
23. NAKAZAWA K, IJIMA H, FUKUDA J et al. Development of a hybrid artificial liver using polyurethane foam/hepatocyte spheroid culture in a preclinical pig experiment. Int J Artif Organs 2002; 25: 51.
24. JASMUND I, LANGSCH A, SIMMOTEIT R, BADER A. Cultivation of primary porcine hepatocytes in an OXY-HFB for use as a bioartificial liver device. Biotechnol Prog 2002; 18: 839.
25. LINTI C, ZIPFEL A, SCHENK M et al. Cultivation of porcine hepatocytes in polyurethane nonwovens as part of a biohybrid liver support system. Int J Artif Organs 2002; 25: 994.
26. NEWSOME PN, PLEVRIS JN, NELSON LJ, HAYES PC. Animal models of fulminant hepatic failure: a critical evaluation. Liver Transpl 2000; 6: 21.
27. KOBAYASHI N, FUJIWARA T, WESTERMAN KA et al. Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science 2000; 287: 1258.
28. KOBAYASHI N, MIYAZAKI M, FUKAYA K et al. Transplantation of highly differentiated immortalized human hepatocytes to treat acute liver failure. Transplantation 2000; 69: 202.
29. NAKAMURA J, OKAMOTO T, SCHUMACHER IK et al. Treatment of surgically induced acute liver failure by transplantation of conditionally immortalized hepatocytes. Transplantation 1997; 63: 1541.
30. EGUCHI S, ROZGA J, LEBOW LT et al. Treatment of hypercholesterolaemia in the Watanabe rabbit using allogeneic hepatocellular transplantation under a regenerative stimulus. Transplantation 1996; 62: 588.
31. MOSCIONI AD, ROZGA J, CHEN S et al. Long-term correction of albumin levels in the Nagase analbuminemic rat: repopulation of the liver by transplanted normal hepatocytes under a regeneration response. Cell Transplant 1996; 5: 499.
32. MOSCIONI AD, ROY CHOWDHURY J, BARBOUR R et al. Human liver cell transplantation: prolonged function in athymic Gunn and athymic analbuminaemic hybrid rat. Gastroenterology 1989; 96: 1546.
33. DEMETRIOU AA, WHITING JF, FELDMAN D et al. Replacement of liver function in rats by transplantation of micro carrier attached hepatocytes. Science 1986; 233: 1190.
34. SCHUMACHER IK, OKAMOTO T, KIM BH et al. Transplantation of conditionally immortalized hepatocytes to treat hepatic encephalopathy. Hepatology 1996; 24: 337.
35. TADA K, ROY-CHOWDHURY N, PRASAD V et al. Long-term amelioration of bilirubin glucuronidation defect in Gunn rats by transplanting genetically modified immortalized autologous hepatocytes. Cell Transplant 1998; 7: 607.